Jove
Visualize
Contact Us

Related Concept Videos

CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

920
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
920
Depressants01:28

Depressants

330
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
330
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

608
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
608
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

685
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
685
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

11.4K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.4K
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

1.0K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Monlunabant in adults with obesity and metabolic syndrome: Open-label extension of a phase 2a trial.

Diabetes, obesity & metabolism·2026
Same author

CB<sub>1</sub> receptors on a subset of vagal afferent neurons modulate voluntary ethanol intake in mice.

Molecular psychiatry·2025
Same author

Gut cannabinoid receptor 1 regulates alcohol binge-induced intestinal permeability.

eGastroenterology·2025
Same author

Structural mechanism of CB<sub>1</sub>R binding to peripheral and biased inverse agonists.

Nature communications·2024
Same author

Coordinated action of a gut-liver pathway drives alcohol detoxification and consumption.

Nature metabolism·2024
Same author

Renal Mitochondrial ATP Transporter Ablation Ameliorates Obesity-Induced CKD.

Journal of the American Society of Nephrology : JASN·2024
Same journal

COVID-19 pandemic-related changes in utilization of telehealth and treatment overall for alcohol use problems.

Alcoholism, clinical and experimental research·2022
Same journal

The relationship between fathers' heavy episodic drinking and fathering involvement in five Asia-Pacific countries: An individual participant data meta-analysis.

Alcoholism, clinical and experimental research·2022
Same journal

Screening for hazardous alcohol use in the Emergency Department: Comparison of phosphatidylethanol with the Alcohol Use Disorders Identification Test and the Timeline Follow-back.

Alcoholism, clinical and experimental research·2022
Same journal

Combination treatment with varenicline and naltrexone reduces World Health Organization risk drinking levels.

Alcoholism, clinical and experimental research·2022
Same journal

College students' virtual and in-person drinking contexts during the COVID-19 pandemic.

Alcoholism, clinical and experimental research·2022
Same journal

Does state repeal of alcohol exclusion laws increase problem drinking?

Alcoholism, clinical and experimental research·2022
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Dec 28, 2025

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

1.4K

Interactions Between Alcohol and the Endocannabinoid System.

George Kunos1

  • 1From the, Division of Clinical and Biological Research, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland.

Alcoholism, Clinical and Experimental Research
|February 15, 2020
PubMed
Summary
This summary is machine-generated.

Endocannabinoids and alcohol impact the brain and liver through cannabinoid-1 receptors (CB1R). Blocking CB1R may offer therapeutic potential for addiction and alcohol-induced liver disease.

Keywords:
Alcohol Drinking BehaviorAlcoholic Liver DiseaseCannabinoid ReceptorsEndocannabinoids

More Related Videos

Disruption of Frontal Lobe Neural Synchrony During Cognitive Control by Alcohol Intoxication
09:26

Disruption of Frontal Lobe Neural Synchrony During Cognitive Control by Alcohol Intoxication

Published on: February 6, 2019

21.9K
Flypub To Study Ethanol Induced Behavioral Disinhibition and Sensitization
08:13

Flypub To Study Ethanol Induced Behavioral Disinhibition and Sensitization

Published on: May 18, 2020

6.9K

Related Experiment Videos

Last Updated: Dec 28, 2025

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

1.4K
Disruption of Frontal Lobe Neural Synchrony During Cognitive Control by Alcohol Intoxication
09:26

Disruption of Frontal Lobe Neural Synchrony During Cognitive Control by Alcohol Intoxication

Published on: February 6, 2019

21.9K
Flypub To Study Ethanol Induced Behavioral Disinhibition and Sensitization
08:13

Flypub To Study Ethanol Induced Behavioral Disinhibition and Sensitization

Published on: May 18, 2020

6.9K

Area of Science:

  • Neuroscience
  • Hepatology
  • Pharmacology

Background:

  • Endocannabinoids are endogenous lipid mediators interacting with cannabinoid receptors, similar to THC.
  • Alcohol and THC are addictive substances that activate similar reward pathways in the brain.
  • Both alcohol and endocannabinoids promote fatty liver disease by activating lipogenic gene expression.

Purpose of the Study:

  • To review evidence on the role of endocannabinoid signaling via CB1R in alcohol's neural and organ toxic effects.
  • To explore the therapeutic potential of CB1R blockade for alcohol-related conditions.

Main Methods:

  • Literature review of studies from the last two decades.
  • Analysis of research on endocannabinoid signaling pathways.
  • Examination of studies investigating CB1R blockade.

Main Results:

  • Ethanol's addictive neural effects are largely mediated by endocannabinoid signaling through CB1R.
  • Alcohol's organ toxicity, particularly in the liver, is also significantly influenced by endocannabinoid/CB1R pathways.
  • Evidence suggests CB1R plays a critical role in mediating both the rewarding and toxic effects of alcohol.

Conclusions:

  • Endocannabinoid signaling via CB1R is a key mechanism underlying alcohol addiction and organ damage.
  • Targeting CB1R, either globally or peripherally, presents a promising therapeutic strategy for managing alcohol use disorder and its associated pathologies.